Expression of 3q Oncogene SEC62 Predicts Survival in Head and Neck Squamous Cell Carcinoma Patients Treated with Primary Chemoradiation.
- Resource Type
- Article
- Source
- Cancers; Jan2024, Vol. 16 Issue 1, p98, 14p
- Subject
SURVIVAL ONCOGENES IMMUNOHISTOCHEMISTRY HEAD & neck cancer REGRESSION analysis METASTASIS CANCER patients GENE expression CHEMORADIOTHERAPY DESCRIPTIVE statistics RESEARCH funding PREDICTION models DATA analysis software TUMOR markers PROGRESSION-free survival SQUAMOUS cell carcinoma LONGITUDINAL method - Language
- ISSN
- 20726694